BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23752102)

  • 1. Adrenocortical carcinoma is a lynch syndrome-associated cancer.
    Raymond VM; Everett JN; Furtado LV; Gustafson SL; Jungbluth CR; Gruber SB; Hammer GD; Stoffel EM; Greenson JK; Giordano TJ; Else T
    J Clin Oncol; 2013 Aug; 31(24):3012-8. PubMed ID: 23752102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Adrenocortical Carcinoma Associated With Lynch Syndrome.
    Domènech M; Grau E; Solanes A; Izquierdo A; Del Valle J; Carrato C; Pineda M; Dueñas N; Pujol M; Lázaro C; Capellà G; Brunet J; Navarro M
    J Clin Endocrinol Metab; 2021 Jan; 106(2):318-325. PubMed ID: 33185660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Adrenocortical Carcinoma in Association With Lynch Syndrome.
    Challis BG; Kandasamy N; Powlson AS; Koulouri O; Annamalai AK; Happerfield L; Marker AJ; Arends MJ; Nik-Zainal S; Gurnell M
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2269-72. PubMed ID: 27144940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET.
    Raygada M; Raffeld M; Bernstein A; Miettinen M; Glod J; Hughes MS; Reilly K; Widemann B; Del Rivero J
    Am J Med Genet A; 2021 Apr; 185(4):1282-1287. PubMed ID: 33615670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
    Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
    PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
    Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic Insights into DNA Mismatch Repair (MMR) Genes-Proteins and Microsatellite Instability: Focus on Adrenocortical Carcinoma and Beyond.
    Carsote M; Turturea IF; Turturea MR; Valea A; Nistor C; Gheorghisan-Galateanu AA
    Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
    Raymond VM; Else T; Everett JN; Long JM; Gruber SB; Hammer GD
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E119-25. PubMed ID: 23175693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic, retroperitoneal adrenocortical carcinoma in the setting of Lynch syndrome.
    Wright JP; Montgomery KW; Tierney J; Gilbert J; Solórzano CC; Idrees K
    Fam Cancer; 2018 Jul; 17(3):381-385. PubMed ID: 28940135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
    Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
    Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
    Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP
    Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
    Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
    Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
    Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome.
    Medina-Arana V; Delgado L; González L; Bravo A; Díaz H; Salido E; Riverol D; González-Aguilera JJ; Fernández-Peralta AM
    Fam Cancer; 2011 Jun; 10(2):265-71. PubMed ID: 21225464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
    Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
    Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype: 5th International ACC Symposium Session: Not Just for Kids!
    Else T; Rodriguez-Galindo C
    Horm Cancer; 2016 Feb; 7(1):36-9. PubMed ID: 26660147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.